Acarix AB (publ)
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauri… Read more
Acarix AB (publ) (ACIXF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.186x
Based on the latest financial reports, Acarix AB (publ) (ACIXF) has a cash flow conversion efficiency ratio of -0.186x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.16 Million) by net assets ($38.48 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Acarix AB (publ) - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Acarix AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Acarix AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Acarix AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TWi Biotechnology, Inc.
TWO:6610
|
-0.251x |
|
Pacific Century Premium Developments Limited
PINK:PCPDF
|
-1.695x |
|
ENGIE Eps S.A
F:8XE
|
-0.075x |
|
ELUON Corporation
KQ:065440
|
-0.017x |
|
Mohenz.Co.Ltd
KQ:006920
|
0.017x |
|
Benfica
LS:SLBEN
|
-0.164x |
|
Wheels Up Experience Inc
NYSE:UP
|
0.099x |
|
FSA Group Ltd
AU:FSA
|
0.105x |
Annual Cash Flow Conversion Efficiency for Acarix AB (publ) (2014–2024)
The table below shows the annual cash flow conversion efficiency of Acarix AB (publ) from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $75.70 Million | $-63.33 Million | -0.837x | +46.65% |
| 2023-12-31 | $51.88 Million | $-81.37 Million | -1.568x | -8.55% |
| 2022-12-31 | $51.83 Million | $-74.87 Million | -1.445x | -202.56% |
| 2021-12-31 | $100.54 Million | $-48.01 Million | -0.477x | -6.90% |
| 2020-12-31 | $82.14 Million | $-36.69 Million | -0.447x | +23.17% |
| 2019-12-31 | $76.60 Million | $-44.53 Million | -0.581x | -32.32% |
| 2018-12-31 | $9.91 Million | $-4.36 Million | -0.439x | -39.72% |
| 2017-12-31 | $15.72 Million | $-4.94 Million | -0.314x | -440.01% |
| 2016-12-31 | $17.07 Million | $-994.27K | -0.058x | +91.81% |
| 2015-12-31 | $1.44 Million | $-1.02 Million | -0.711x | +48.48% |
| 2014-12-31 | $1.93 Million | $-2.67 Million | -1.380x | -- |